Skip to main content
Terug
IMBBF logo

Imperial Brands PLC

Datakwaliteit: 100%
IMBBF
OTC Consumer Defensive Tobacco
€ 42,42
▲ € 1,72 (4,23%)
Marktkapitalisatie: 33,25B
Ook genoteerd als IMBBY OTC
Dagbereik
€ 40,17 € 42,63
52-Weeksbereik
€ 34,82 € 47,18
Volume
110
50D / 200D Gem.
€ 42,93 / € 41,66
Vorige Slotkoers
€ 40,70

Koershistorie

Financiële Trends

Sectorvergelijking

vs Consumer Defensive sector mediaan (329 peers)

Metriek Aandeel Sector Mediaan
P/E 11,9 10,4
P/B 6,9 1,2
ROE % 54,2 12,6
Net Margin % 10,9 5,3
Rev Growth 5Y % -6,1 5,5
D/E 2,1 0,6

Belangrijkste Punten

Revenue declined -6,08% annually over 5 years
ROE of 54,23% indicates high profitability
Debt/Equity of 2,07 — high leverage
Generating 3,84B in free cash flow
P/E of 11,94 — trading at a low valuation
PEG of 0,78 suggests growth is underpriced

Groei

Revenue Growth (5Y)
-6,08%
Revenue (1Y)-21,27%
Earnings (1Y)6,54%
FCF Growth (3Y)14,21%

Kwaliteit

Return on Equity
54,23%
ROIC25,37%
Net Margin10,91%
Op. Margin19,64%

Veiligheid

Debt / Equity
2,07
Current Ratio0,74
Interest Coverage8,73

Waardering

P/E Ratio
11,94
P/B Ratio6,89
EV/EBITDA8,34
Dividend Yield0,08%

All Fundamental Metrics

Growth
Revenue Growth (1Y) -21,27% Revenue Growth (3Y) 18,81%
Earnings Growth (1Y) 6,54% Earnings Growth (3Y) 9,35%
Revenue Growth (5Y) -6,08% Earnings Growth (5Y) -0,45%
Profitability
Revenue (TTM) 25,52B Net Income (TTM) 2,78B
ROE 54,23% ROA 9,69%
Gross Margin 34,94% Operating Margin 19,64%
Net Margin 10,91% Free Cash Flow (TTM) 3,84B
ROIC 25,37% FCF Growth (3Y) 14,21%
Safety
Debt / Equity 2,07 Current Ratio 0,74
Interest Coverage 8,73 Dividend Yield 0,08%
Valuation
P/E Ratio 11,94 P/B Ratio 6,89
P/S Ratio 1,30 PEG Ratio 0,78
EV/EBITDA 8,34 Dividend Yield 0,08%
Market Cap 33,25B Enterprise Value 41,81B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 25,52B 32,41B 18,08B 32,55B 32,79B
Net Income 2,78B 2,61B 2,33B 1,57B 2,83B
EPS (Diluted) 3,35 2,99 2,51 1,65 2,99
Gross Profit 8,92B 6,78B 6,68B 6,04B 6,03B
Operating Income 5,01B 3,55B 3,40B 2,68B 3,15B

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 28,72B 27,83B 29,49B 30,96B 29,09B
Total Liabilities 23,28B 21,80B 22,85B 23,49B 23,15B
Shareholders' Equity 4,82B 5,44B 6,02B 6,86B 5,35B
Total Debt 10,00B 9,08B 9,73B 10,26B 10,07B
Cash & Equivalents 1,44B 1,08B 1,35B 1,85B 1,29B
Current Assets 8,81B 8,20B 8,60B 8,92B 8,21B
Current Liabilities 11,85B 11,46B 11,90B 11,14B 10,81B

Strategiescores

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
Custom Contrarian Investing (David Dreman)
#161 of 658
50

Recente Activiteit

Ingestapt Contrarian Investing (David Dreman)
Mar 24, 2026